Characterizing COVID-19 and Influenza Illnesses in the Real World via Person-Generated Health Data.

COVID-19 Fitbit SARS-CoV-2 activity tracker digital health flu influenza-like illness person-generated health data symptom presentation

Journal

Patterns (New York, N.Y.)
ISSN: 2666-3899
Titre abrégé: Patterns (N Y)
Pays: United States
ID NLM: 101767765

Informations de publication

Date de publication:
08 Jan 2021
Historique:
received: 22 07 2020
revised: 19 11 2020
accepted: 10 12 2020
entrez: 28 1 2021
pubmed: 29 1 2021
medline: 29 1 2021
Statut: epublish

Résumé

The fight against COVID-19 is hindered by similarly presenting viral infections that may confound detection and monitoring. We examined person-generated health data (PGHD), consisting of survey and commercial wearable data from individuals' everyday lives, for 230 people who reported a COVID-19 diagnosis between March 30, 2020, and April 27, 2020 (n = 41 with wearable data). Compared with self-reported diagnosed flu cases from the same time frame (n = 426, 85 with wearable data) or pre-pandemic (n = 6,270, 1,265 with wearable data), COVID-19 patients reported a distinct symptom constellation that lasted longer (median of 12 versus 9 and 7 days, respectively) and peaked later after illness onset. Wearable data showed significant changes in daily steps and prevalence of anomalous resting heart rate measurements, of similar magnitudes for both the flu and COVID-19 cohorts. Our findings highlight the need to include flu comparator arms when evaluating PGHD applications aimed to be highly specific for COVID-19.

Identifiants

pubmed: 33506230
doi: 10.1016/j.patter.2020.100188
pii: S2666-3899(20)30258-0
pmc: PMC7815963
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100188

Informations de copyright

© 2021 The Authors.

Déclaration de conflit d'intérêts

A.S., N.M., I.C., B.B., E.R., J.M., and L.F. are employees of Evidation, a company that runs research studies using person-generated health data in several therapeutic areas, including COVID-19. All other authors declare no competing interests.

Références

Am J Public Health. 2015 Oct;105(10):2124-30
pubmed: 26270299
Epidemiol Infect. 2020 Sep 02;148:e197
pubmed: 32873357
MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):790-794
pubmed: 32584797
BMJ. 2020 Aug 13;370:m3218
pubmed: 32816748
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Nat Rev Drug Discov. 2020 Jun;19(6):378-379
pubmed: 32409759
Korean J Fam Med. 2017 Jan;38(1):8-13
pubmed: 28197327
JMIR Public Health Surveill. 2020 Apr 16;6(2):e18980
pubmed: 32297868
PLoS One. 2020 Dec 10;15(12):e0243693
pubmed: 33301493
Nat Hum Behav. 2020 Sep;4(9):972-982
pubmed: 32848231
MMWR Morb Mortal Wkly Rep. 2020 Jun 19;69(24):759-765
pubmed: 32555134
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Sci Adv. 2021 Mar 5;7(10):
pubmed: 33674304
IEEE Open J Eng Med Biol. 2020 Aug 07;1:243-248
pubmed: 34192282
BMJ Open. 2020 Aug 16;10(8):e039652
pubmed: 32801208
PLoS Med. 2020 Sep 22;17(9):e1003379
pubmed: 32960880
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Lancet Digit Health. 2020 Feb;2(2):e85-e93
pubmed: 33334565
Health Expect. 2021 Apr;24(2):377-385
pubmed: 33434404
Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
Clin Infect Dis. 2021 May 4;72(9):e426-e428
pubmed: 32687197
IEEE Open J Eng Med Biol. 2020 Aug 26;1:249-256
pubmed: 35402939
Nat Biomed Eng. 2020 Dec;4(12):1208-1220
pubmed: 33208926
Am J Cardiol. 2014 Feb 15;113(4):644-9
pubmed: 24393259
NPJ Digit Med. 2020 Nov 30;3(1):156
pubmed: 33299095
JAMA Netw Open. 2020 Jul 1;3(7):e2016818
pubmed: 32735339
J Phys Act Health. 2011 Jul;8(5):693-8
pubmed: 21734315
JAMA. 2020 May 19;323(19):1891-1892
pubmed: 32293639
Ann Intern Med. 2017 Nov 21;167(10):755-757
pubmed: 28973116
J Gen Intern Med. 2021 Mar;36(3):738-745
pubmed: 33443703
Nat Med. 2020 Jul;26(7):1037-1040
pubmed: 32393804
MMWR Morb Mortal Wkly Rep. 2020 May 08;69(18):545-550
pubmed: 32379729
Nat Med. 2021 Jan;27(1):73-77
pubmed: 33122860
Sci Adv. 2021 Jan 1;7(1):
pubmed: 33219112
JMIR Res Protoc. 2019 Jan 21;8(1):e10974
pubmed: 30664491

Auteurs

Allison Shapiro (A)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Nicole Marinsek (N)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Ieuan Clay (I)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Benjamin Bradshaw (B)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Ernesto Ramirez (E)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Jae Min (J)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Andrew Trister (A)

Bill and Melinda Gates Foundation, Seattle, WA 98109, USA.

Yuedong Wang (Y)

Department of Statistics and Applied Probability, University of California Santa Barbara, Santa Barbara, CA 93106, USA.

Tim Althoff (T)

Allen School of Computer Science & Engineering, University of Washington, Seattle, WA 98115, USA.

Luca Foschini (L)

Evidation Health, Inc., San Mateo, CA 94401, USA.

Classifications MeSH